Stock listing

NASDAQ:BTAI BioXcel Therapeutics, Inc. Stock

Home listing (NASDAQ) of BioXcel Therapeutics, Inc.

Follow BioXcel Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BTAI

$0.048 USD -0.002 (-3.3%)

Close on Oct 8, 2026 · Data provided by Twelve Data

Past year -98.2% · daily closes, Oct 8, 2025 – Oct 8, 2026, adjusted for splits
Day range
$0.040 – $0.055 USDOct 8, 2026
Volume
70,578 sharesOct 8, 2026
52-week range
$0.019 – $2.870 USDLowest and highest trades, Oct 9, 2025 – Oct 8, 2026
BioXcel Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BTAI · Home$0.048 USD-0.002 (-3.3%)70,578$0.045$0.055$0.040$0.050Close on Oct 8, 2026

Data provided by Twelve Data

Daily closes

Last 3 months, Jul 8, 2026 – Oct 8, 2026 · NASDAQ:BTAI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.048-0.002-3.3%$0.045$0.055$0.04070,578
$0.050-0.003-6.2%$0.056$0.056$0.044169,927
$0.053+0.006+13.3%$0.047$0.070$0.047278,004
$0.047-0.005-10.5%$0.047$0.062$0.040202,641
$0.052+0.007+15.6%$0.050$0.060$0.045347,160
$0.045-0.004-9.0%$0.046$0.050$0.041220,560
$0.049+0.000+1.0%$0.049$0.060$0.043422,760
$0.049+0.008+19.2%$0.031$0.052$0.0311,047,987
$0.041+0.003+7.0%$0.041$0.041$0.035623,491
$0.038+0.003+8.8%$0.035$0.050$0.034289,346
$0.035-0.010-21.6%$0.047$0.051$0.032391,678
$0.045+0.000+1.0%$0.052$0.052$0.032838,101
$0.045-0.017-27.6%$0.052$0.069$0.0401,115,914
$0.062+0.004+6.0%$0.051$0.070$0.051291,674
$0.058-0.017-22.8%$0.061$0.075$0.051153,616
$0.075+0.008+12.3%$0.063$0.080$0.050308,741
$0.067+0.022+49.7%$0.049$0.071$0.0411,165,050
$0.0450.000-0.9%$0.040$0.050$0.040597,837
$0.045-0.006-11.6%$0.040$0.055$0.032509,413
$0.051+0.001+2.0%$0.052$0.058$0.045485,472
$0.050+0.003+6.4%$0.044$0.057$0.040953,200
$0.047+0.004+9.5%$0.043$0.060$0.0344,103,000
$0.043-0.031-41.9%$0.019$0.044$0.0196,288,291
$0.074-0.044-37.4%$0.091$0.094$0.06947,480,718
$0.118+0.011+10.3%$0.120$0.127$0.110151,001,600
$0.107-0.030-21.9%$0.130$0.197$0.10646,794,600
$0.137-0.026-16.0%$0.140$0.142$0.12015,689,100
$0.163-0.018-9.9%$0.151$0.170$0.14210,782,700
$0.181-0.538-74.8%$0.224$0.230$0.15758,562,800
$0.719-0.061-7.8%$0.749$0.763$0.7001,084,200
$0.780+0.038+5.1%$0.758$0.785$0.736900,300
$0.742-0.019-2.5%$0.783$0.811$0.7111,580,400
$0.761-0.043-5.3%$0.800$0.833$0.7511,119,800
$0.804+0.005+0.6%$0.810$0.859$0.7921,239,600
$0.799-0.028-3.4%$0.840$0.840$0.798902,300
$0.827+0.035+4.4%$0.790$0.864$0.790797,600
$0.792-0.098-11.0%$0.850$0.896$0.7801,848,100
$0.890-0.300-25.2%$1.030$1.030$0.8502,199,600
$1.190+0.060+5.3%$1.110$1.240$1.0152,031,400
$1.130+0.070+6.6%$1.100$1.160$1.0501,087,200
$1.060+0.128+13.7%$0.960$1.090$0.9601,112,500
$0.932+0.004+0.4%$0.965$1.020$0.922922,500
$0.928+0.026+2.9%$0.900$0.958$0.893639,100
$0.902+0.072+8.7%$0.840$0.920$0.840526,200
$0.830-0.011-1.3%$0.840$0.850$0.800355,400
$0.841-0.020-2.3%$0.870$0.886$0.840319,900
$0.861+0.013+1.5%$0.860$0.890$0.860457,400
$0.848+0.040+5.0%$0.814$0.880$0.800695,500
$0.808+0.015+1.9%$0.794$0.840$0.780499,500
$0.793-0.009-1.1%$0.790$0.813$0.746763,400
$0.802-0.043-5.1%$0.842$0.845$0.790376,300
$0.845-0.022-2.5%$0.878$0.878$0.830370,100
$0.867+0.019+2.2%$0.848$0.878$0.840262,000
$0.848-0.022-2.5%$0.886$0.886$0.830259,100
$0.870-0.010-1.1%$0.876$0.901$0.841344,800
$0.880-0.018-2.0%$0.909$0.924$0.871250,600
$0.898+0.015+1.7%$0.887$0.910$0.860278,500
$0.883-0.004-0.5%$0.890$0.920$0.840461,700
$0.887+0.017+2.0%$0.865$0.889$0.800647,300
$0.870-0.052-5.6%$0.907$0.930$0.851749,700
$0.922-0.108-10.5%$1.040$1.050$0.8921,565,500
$1.030+0.148+16.8%$0.880$1.170$0.8804,830,300
$0.882+0.064+7.8%$0.810$0.929$0.8101,456,500
$0.818-0.020-2.4%$0.830$0.867$0.790712,100
$0.838+0.036+4.5%$0.800$0.880$0.7372,210,500
$0.802-0.238-22.9%$1.050$1.050$0.7955,211,400
Ticker
NASDAQ:BTAI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Bioxcel Therapeutics (NASDAQ:BTAI) Q3 2024 Earnings Call

    Thu, Nov 14, 2024 · 8:00 AM ET

    Watch Transcript

  • Bioxcel Therapeutics (NASDAQ:BTAI) Q2 2024 Earnings Call

    Tue, Aug 06, 2024 · 8:00 AM ET

    Watch Transcript

  • Bioxcel Therapeutics (NASDAQ:BTAI) Q1 2024 Earnings Call

    Thu, May 09, 2024 · 8:00 AM ET

    Watch Transcript

Latest news

BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting

May 28, 2026

Closed $1.26 (-3.8%) on May 28, 2026

BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

May 15, 2026

Closed $1.14 (-5.8%) on May 15, 2026

BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

Apr 17, 2026

Closed $1.15 (+7.5%) on Apr 17, 2026

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

Apr 8, 2026

Closed $1.10 (+0.9%) on Apr 8, 2026

BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting

Apr 1, 2026

Closed $1.22 (-9.0%) on Apr 1, 2026

BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI Approval in Outpatient Setting

Mar 30, 2026

Closed $1.21 (-4.0%) on Mar 30, 2026

BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering

Mar 11, 2026

Closed $1.57 (+1.3%) on Mar 11, 2026

BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering

Mar 10, 2026

Closed $1.55 (-10.4%) on Mar 10, 2026

BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal

Mar 5, 2026

Closed $1.61 (-2.4%) on Mar 5, 2026

BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s Dementia

Feb 19, 2026

Closed $1.62 (+2.5%) on Feb 19, 2026

All BioXcel Therapeutics, Inc. news

Decks

BioXcel Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 174 in all · newest May 28, 2026 · oldest 2019
Calls
14 calls with a replay · 14 with a transcript · latest Nov 14, 2024
Decks
21 decks · latest November 2025

Where BioXcel Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BTAI · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BTAIBOATSUnited StatesUSD
LS Exchange:A40YSRLS ExchangeGermanyEUR
gettex:BX20gettexGermanyEUR
Lang & Schwarz:A40YSRLang & SchwarzGermanyEUR
Tradegate:BX20TradegateGermanyEUR
Dusseldorf:BX20DusseldorfGermanyEUR
Frankfurt:BX20FrankfurtGermanyEUR
Hamburg:BX20HamburgGermanyEUR
Munich:BX20MunichGermanyEUR
Stuttgart:BX20StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about BioXcel Therapeutics, Inc.